Gainers & Losers
Thu Mar 12 2026 09:59:59- NTPC share price
- ₹390.452.75%
- Power Grid Corporation of ...
- ₹303.701.64%
- Tech Mahindra share price
- ₹1,349.801.19%
- HCL Technologies share price
- ₹1,357.700.57%
Active Stocks
Thu Mar 12 2026 10:15:12- Eternal share price
- ₹221.25-1.14%
- Suzlon Energy share price
- ₹42.462.04%
- Adani Power share price
- ₹149.107.38%
- Yes Bank share price
- ₹19.31-1.13%
- Tata Power Company share price
- ₹402.304.44%
Concord Biotech Balance Sheet Annual
1,173.50 +15.55 (1.34%)Updated : 12 Mar 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 2,034.25 | 1,700.71 | 1,513.98 | 1,312.80 |
| Accumulated Depreciation Total | -290.43 | -240.15 | -187.31 | -137.85 |
| Other Liabilities Total | 2.82 | 1.96 | 2.30 | 1.87 |
| Accrued Expenses | 0.00 | 0.10 | 0.26 | 0.36 |
| Long Term Debt | 0.00 | 0.00 | 6.24 | 31.25 |
| Common Stock Total | 10.46 | 10.46 | 10.46 | 9.51 |
| Other Current Assets Total | 3.69 | 12.74 | 5.08 | 7.25 |
| Prepaid Expenses | 7.39 | 7.33 | 5.52 | 4.76 |
| Total Assets | 2,034.25 | 1,700.71 | 1,513.98 | 1,312.80 |
| Current Portof LT Debt/ Capital Leases | 2.34 | 7.85 | 25.15 | 26.60 |
| Additional Paid- In Capital | 81.97 | 81.97 | 81.97 | 82.92 |
| Cash | 0.90 | 15.14 | 3.50 | 0.67 |
| Total Equity | 1,812.72 | 1,526.65 | 1,290.00 | 1,103.22 |
| Long Term Investments | 34.76 | 3.05 | 10.32 | 2.75 |
| Retained Earnings( Accumulated Deficit) | 1,720.28 | 1,434.21 | 1,197.57 | 1,010.79 |
| Total Common Shares Outstanding | 10.46 | 10.46 | 10.46 | 10.46 |
| Property/ Plant/ Equipment Total- Gross | 1,134.65 | 1,026.63 | 952.79 | 781.40 |
| Tangible Book Valueper Share Common Eq | 173.17 | 145.90 | 123.29 | 105.11 |
| Total Liabilities | 221.53 | 174.06 | 223.98 | 209.57 |
| Total Debt | 2.97 | 9.74 | 31.55 | 62.49 |
| Short Term Investments | 334.53 | 266.52 | 136.93 | 73.86 |
| Cashand Short Term Investments | 335.44 | 281.67 | 180.38 | 162.79 |
| Total Receivables Net | 547.48 | 378.89 | 323.10 | 260.23 |
| Notes Payable/ Short Term Debt | 0.00 | 0.00 | 0.00 | 4.34 |
| Deferred Income Tax | 34.02 | 28.06 | 23.44 | 20.97 |
| Accounts Receivable- Trade Net | 521.65 | 350.84 | 274.55 | 234.30 |
| Property/ Plant/ Equipment Total- Net | 844.22 | 786.48 | 765.48 | 643.56 |
| Total Current Liabilities | 184.06 | 142.16 | 191.84 | 155.17 |
| Total Inventory | 241.24 | 215.61 | 213.62 | 197.63 |
| Accounts Payable | 113.04 | 94.44 | 93.80 | 83.11 |
| Other Currentliabilities Total | 68.68 | 39.77 | 72.64 | 40.77 |
| Total Long Term Debt | 0.63 | 1.89 | 6.40 | 31.56 |
| Intangibles Net | 1.12 | 0.32 | 0.20 | 3.58 |
| Other Long Term Assets Total | 7.91 | 2.16 | 7.62 | 26.64 |
| Note Receivable- Long Term | 11.00 | 12.47 | 2.67 | 3.60 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,135.24 | 896.23 | 727.70 | 632.67 |
| Capital Lease Obligations | 0.63 | 1.89 | 0.16 | 0.31 |
| Cash Equivalents | - | - | 39.95 | 88.27 |
*All figures in crores except per share values
Concord Biotech Quick Links
Concord Biotech Dividend Concord Biotech Bonus Concord Biotech News Concord Biotech AGM Concord Biotech Rights Concord Biotech Splits Concord Biotech Board Meetings Concord Biotech Key Metrics Concord Biotech Shareholdings Concord Biotech Profit Loss Concord Biotech Cashflow Concord Biotech Q1 Results Concord Biotech Q2 Results Concord Biotech Q3 Results Concord Biotech Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,824.90+11.90(0.66%)
378.50+1.20(0.32%)
893.15-47.10 (-5.01%)
1,259.05-56.00 (-4.26%)